UTHR.NASDAQUnited Therapeutics CORP
Form 4: UNITED THERAPEUTICS CEO Sells Shares
Sentiment:
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on October 14, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $117.76 ($1,118,720) on October 14, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 40 Common Stock at $526.07 ($21,043) on October 14, 2026; holds 333,903 after (Indirect).
- Open-market sale: disposed of 160 Common Stock at $530.09 ($84,814) on October 14, 2026; holds 333,743 after (Indirect).
- Open-market sale: disposed of 120 Common Stock at $531.19 ($63,742) on October 14, 2026; holds 333,623 after (Indirect).
- Open-market sale: disposed of 40 Common Stock at $532.48 ($21,299) on October 14, 2026; holds 333,583 after (Indirect).
- Open-market sale: disposed of 240 Common Stock at $534.63 ($128,312) on October 14, 2026; holds 333,343 after (Indirect).
- Open-market sale: disposed of 400 Common Stock at $535.89 ($214,356) on October 14, 2026; holds 332,943 after (Indirect).
- Open-market sale: disposed of 633 Common Stock at $537.19 ($340,039) on October 14, 2026; holds 332,310 after (Indirect).
- Open-market sale: disposed of 1,127 Common Stock at $538.00 ($606,326) on October 14, 2026; holds 331,183 after (Indirect).
- Open-market sale: disposed of 525 Common Stock at $539.09 ($283,023) on October 14, 2026; holds 330,658 after (Indirect).
- Open-market sale: disposed of 2,002 Common Stock at $540.23 ($1,081,544) on October 14, 2026; holds 328,656 after (Indirect).
- Open-market sale: disposed of 1,930 Common Stock at $541.20 ($1,044,509) on October 14, 2026; holds 326,726 after (Indirect).
- Open-market sale: disposed of 883 Common Stock at $542.07 ($478,644) on October 14, 2026; holds 325,843 after (Indirect).
- Open-market sale: disposed of 400 Common Stock at $543.15 ($217,262) on October 14, 2026; holds 325,443 after (Indirect).
- Open-market sale: disposed of 480 Common Stock at $544.35 ($261,289) on October 14, 2026; holds 324,963 after (Indirect).
- Open-market sale: disposed of 480 Common Stock at $545.48 ($261,830) on October 14, 2026; holds 324,483 after (Indirect).
- Open-market sale: disposed of 40 Common Stock at $546.00 ($21,840) on October 14, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on October 14, 2026; holds 233,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,129,873 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-14 | Option exercise/conversion | Common Stock | 9,500 | $118 | $1.1M | 333,943 |
| 2026-10-14 | Open-market sale | Common Stock | 40 | $526 | $21.0K | 333,903 |
| 2026-10-14 | Open-market sale | Common Stock | 160 | $530 | $84.8K | 333,743 |
| 2026-10-14 | Open-market sale | Common Stock | 120 | $531 | $63.7K | 333,623 |
| 2026-10-14 | Open-market sale | Common Stock | 40 | $532 | $21.3K | 333,583 |
| 2026-10-14 | Open-market sale | Common Stock | 240 | $535 | $128.3K | 333,343 |
| 2026-10-14 | Open-market sale | Common Stock | 400 | $536 | $214.4K | 332,943 |
| 2026-10-14 | Open-market sale | Common Stock | 633 | $537 | $340.0K | 332,310 |
| 2026-10-14 | Open-market sale | Common Stock | 1,127 | $538 | $606.3K | 331,183 |
| 2026-10-14 | Open-market sale | Common Stock | 525 | $539 | $283.0K | 330,658 |
| 2026-10-14 | Open-market sale | Common Stock | 2,002 | $540 | $1.1M | 328,656 |
| 2026-10-14 | Open-market sale | Common Stock | 1,930 | $541 | $1.0M | 326,726 |
| 2026-10-14 | Open-market sale | Common Stock | 883 | $542 | $478.6K | 325,843 |
| 2026-10-14 | Open-market sale | Common Stock | 400 | $543 | $217.3K | 325,443 |
| 2026-10-14 | Open-market sale | Common Stock | 480 | $544 | $261.3K | 324,963 |
| 2026-10-14 | Open-market sale | Common Stock | 480 | $545 | $261.8K | 324,483 |
| 2026-10-14 | Open-market sale | Common Stock | 40 | $546 | $21.8K | 324,443 |
| 2026-10-14 | Option exercise/conversion | Stock Option | 9,500 | — | — | 233,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-14 | Option exercise/conversion (9,500 shares) |
| 2026-10-14 | Open-market sale (40 shares) |
| 2026-10-14 | Open-market sale (160 shares) |
| 2026-10-14 | Open-market sale (120 shares) |
| 2026-10-14 | Open-market sale (40 shares) |
| 2026-10-14 | Open-market sale (240 shares) |
| 2026-10-14 | Open-market sale (400 shares) |
| 2026-10-14 | Open-market sale (633 shares) |
| 2026-10-14 | Open-market sale (1,127 shares) |
| 2026-10-14 | Open-market sale (525 shares) |
| 2026-10-14 | Open-market sale (2,002 shares) |
| 2026-10-14 | Open-market sale (1,930 shares) |
| 2026-10-14 | Open-market sale (883 shares) |
| 2026-10-14 | Open-market sale (400 shares) |
| 2026-10-14 | Open-market sale (480 shares) |
| 2026-10-14 | Open-market sale (480 shares) |
| 2026-10-14 | Open-market sale (40 shares) |
| 2026-10-14 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.